Affiliation:
1. Voronezh State University
Abstract
Introduction. Employees of the Department of Pharmaceutical Chemistry and Pharmaceutical Technology have obtained modified forms of terpino-indole alkaloids (ТIA) and vinbristine (VCR) and vinblastine (VBL) known in the treatment of cancer diseases by incorporating them into the erythrocyte carriers (EN) by the modified method of hypoosmotic lysis in the modified (aprotic solvent dimethyl sulfoxide (DMSO) and polyethylene glycol (PEG 4000) and unmodified media.Aim. The aim of the work was to study the desorption and release of terpene-indole vincristine and vinblastine alkaloids from previously obtained cellular erythrocyte carriers.Materials and methods. In the experiment performed, the release characteristics of encapsulated preparations from erythrocytes were determined. TIA preparations were released from erythrocyte form in 6 hours: VCR – 54.5305%, VCR : PEG-4000 (1:5) – 53.3305%, VCR : PEG-4000 (1:10) – 40.1283%, VCR : PEG-4000 (1:20) – 39.9869%, VCR : DMSO (2 mg/ml) – 54.2354%, VBL – 68.0656%; VBL : PEG-4000 (1:10) – 63.8941%; VBL : PEG-4000 (1:20) – 60.7455%; VBL : PEG-400 (1:20) – 60.3529%; VBL : DMSO (2 mg/ml) – 64.5006%. The rate of release from an erythrocyte form encapsulated in a medium modified with DMSO is significantly higher than that encapsulated in an unmodified medium. The average rate of TIA release from erythrocyte forms encapsulated in PEG medium is approximately the same.Results and discussion. The results show that the release of hemoglobin from TIA encapsulated erythrocytes compared with non-encapsulated EN is small. The results show that, on average, 8.242 ± 0.3135% of hemoglobin is released from TIA encapsulated with EN, compared to control erythrocytes – 7.53% after 6 h of incubation at 37 °C. The release of hemoglobin from the TIA of encapsulated erythrocytes in modified media is less than that encapsulated in unmodified medium.Conclusion. Based on these results, it can be suggested that PEG can bind to the erythrocyte membrane and stabilize it.
Publisher
Center of Pharmaceutical Analytics Ltd
Subject
Drug Discovery,Pharmaceutical Science
Reference32 articles.
1. Trineeva O. V. et al. Morphological and physicochemical properties of erythrocyte carriers encapsulated with terpene-indole alkaloids. Drug development & registration.2018; 1(22): 40–44 (In Russ.).
2. Zaborovsky A. V., Gurevich K. G. Modeling of the directed transport of medicinal substances. Part I. Single management. Siberian Oncology Journal. 2017; 1(16): 59–65 (In Russ.).
3. Zaborovsky A. V., Gurevich K. G. Modeling of the directed transport of medicinal substances. Part II. Repeated introduction. Siberian Oncology Journal. 2017; 2(16): 36–41 (In Russ.).
4. Kseiko D. A., Gening T. P. Efficiency of using autologous blood cells for targeted delivery of ascorbic acid to the liver in order to optimize the colloid osmotic pressure of blood after blood loss. Ulyanovsk Biomedical Journal. 2014; 2: 67–72 (In Russ.).
5. Levin G. Ya., Sosnina L. N. The use of ultraviolet irradiation of erythrocytes to increase their ability to deposit drugs. Medical Almonas. 2013; 3(27): 67–69 (In Russ.).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献